Intelligent Bio Solutions Price to Sales Ratio 2020-2024 | INBS
Historical PS ratio values for Intelligent Bio Solutions (INBS) over the last 10 years. The current P/S ratio for Intelligent Bio Solutions as of January 03, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Intelligent Bio Solutions P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-01-03 | 1.48 | 0.69 | |
| 2024-09-30 | 1.73 | $2.15 | 0.80 |
| 2024-06-30 | 1.92 | $6.02 | 0.32 |
| 2024-03-31 | 4.22 | $19.41 | 0.22 |
| 2023-12-31 | 0.34 | $23.96 | 0.01 |
| 2023-09-30 | 1.03 | $27.87 | 0.04 |
| 2023-06-30 | 2.78 | $23.77 | 0.12 |
| 2023-03-31 | 2.90 | $9.66 | 0.30 |
| 2022-12-31 | 0.20 | $4.71 | 0.04 |
| 2022-09-30 | 0.42 | 0 | 0.00 |
| 2022-06-30 | 0.66 | 0 | 0.00 |
| 2022-03-31 | 0.78 | $37.04 | 0.02 |
| 2021-12-31 | 1.44 | $37.74 | 0.04 |
| 2021-09-30 | 2.52 | $45.63 | 0.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.003B |
| Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.844B | 10.53 |
| Cencora (COR) | United States | $43.438B | 16.33 |
| DiDi Global (DIDIY) | China | $22.990B | 0.00 |
| Natera (NTRA) | United States | $21.203B | 0.00 |
| ICON (ICLR) | Ireland | $17.541B | 15.62 |
| Viatris (VTRS) | United States | $14.824B | 4.57 |
| Avantor (AVTR) | United States | $14.429B | 21.63 |
| Revvity (RVTY) | United States | $13.631B | 23.68 |
| BioMerieux (BMXMF) | France | $12.250B | 0.00 |
| CochLear (CHEOY) | Australia | $11.924B | 0.00 |
| Solventum (SOLV) | United States | $11.390B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.405B | 29.31 |
| Doximity (DOCS) | United States | $9.999B | 58.86 |
| Charles River Laboratories (CRL) | United States | $9.340B | 18.05 |
| HealthEquity (HQY) | United States | $8.390B | 42.09 |
| Sonic Healthcare (SKHHY) | Australia | $8.095B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.858B | 20.64 |
| Organon (OGN) | United States | $3.853B | 3.89 |
| BrightSpring Health Services (BTSG) | United States | $3.018B | 64.18 |
| Surgery Partners (SGRY) | United States | $2.706B | 30.85 |
| Concentras Parent (CON) | United States | $2.456B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.405B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.216B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.054B | 10.69 |
| PACS (PACS) | United States | $1.971B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.738B | 45.60 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.720B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.639B | 0.00 |
| Progyny (PGNY) | United States | $1.510B | 30.57 |
| Establishment Labs Holdings (ESTA) | $1.268B | 0.00 | |
| Embecta (EMBC) | United States | $1.177B | 8.23 |
| CareDx (CDNA) | United States | $1.154B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.119B | 10.95 |
| AMN Healthcare Services Inc (AMN) | United States | $0.935B | 6.33 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| SBC Medicals (SBC) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.566B | 14.81 |
| InnovAge Holding (INNV) | United States | $0.534B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| DocGo (DCGO) | United States | $0.438B | 16.50 |
| Sonida Senior Living (SNDA) | United States | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 33.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.281B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.237B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.215B | 0.00 |
| MultiPlan (MPLN) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Nutex Health (NUTX) | United States | $0.189B | 0.00 |
| ModivCare (MODV) | United States | $0.177B | 9.60 |
| So-Young (SY) | China | $0.097B | 16.41 |
| Ascend Wellness Holdings (AAWH) | United States | $0.093B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |